Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Other, 2025

Indivior Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2025-11-06: Form 10-Q; Item Shares outstanding as of 2025-10-29; As filed 57,339,350.
  • 2025-08-05: Form 10-Q; Item Shares outstanding as of 2025-07-29; As filed 56,073,088.
  • 2025-05-06: Form 10-Q; Item Shares outstanding as of 2025-04-29; As filed 55,989,623.
  • 2025-02-25: Form 10-K; Item Shares outstanding as of 2025-02-18; As filed 55,814,496.
FiledFormItemAs filed
2025-11-0610-QShares outstanding as of 2025-10-2957,339,350
2025-08-0510-QShares outstanding as of 2025-07-2956,073,088
2025-05-0610-QShares outstanding as of 2025-04-2955,989,623
2025-02-2510-KShares outstanding as of 2025-02-1855,814,496
2025-02-2510-KPublic float as of 2024-06-30$1.41B
2025-02-2510-KStock registered under Section 12(b)Common Stock, $0.001 Par Value · SUPN · NASDAQ

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38